INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

↓ Download CSV

CIK 0000917520 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, INTEGRA LIFESCIENCES HOLDINGS CORP reported revenue of $1.64B, up 1.5% from the prior year. The company ran a net loss, with a net margin of -31.6%. It held $3.60B in total assets against $2.56B in total liabilities.

Key ratios (FY2025)

-30.2%
Operating margin
-31.6%
Net margin
-49.5%
Return on equity
+1.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.64B$1.61B$1.54B$1.56B$1.54B$1.37B$1.52B$1.47B$1.19B$992.08M
Cost of Revenue$803.62M$728.47M$656.84M$587.36M$597.81M$520.83M$564.68M$571.50M$435.51M$349.09M
Gross Profit$851.03M$952.88M$900.95M$752.73M$642.99M
Operating Income-$493.37M$28.41M$111.53M$238.92M$197.23M$151.37M$93.76M$111.00M$44.80M$115.34M
Net Income-$516.47M-$6.94M$67.74M$180.55M$169.07M$133.89M$50.20M$60.80M$64.74M$74.56M
EPS (Diluted)$-6.74$-0.09$0.84$2.16$1.98$1.57$0.58$0.72$0.82$0.94
Total Assets$3.60B$4.04B$3.78B$3.89B$3.78B$3.62B$3.30B$3.11B$3.21B$1.81B
Total Liabilities$2.56B$2.49B$2.19B$2.09B$2.10B$2.10B$1.89B$1.73B$2.25B$968.29M
Shareholders' Equity$1.04B$1.55B$1.59B$1.80B$1.68B$1.51B$1.42B$1.38B$962.31M$839.67M
Cash & Equivalents$235.05M$246.38M$276.40M$456.66M$513.45M$470.17M$198.91M$138.84M$174.94M$102.06M
Operating Cash Flow$50.38M$129.38M$139.96M$264.47M$312.43M$203.83M$231.43M$199.68M$114.54M$116.41M
Capital Expenditures$81.44M$104.42M$66.86M$42.34M$48.02M$38.89M$69.54M$77.74M$43.50M$47.33M
Shares Outstanding76.67M77.01M80.34M83.52M85.48M85.23M86.49M84.00M79.12M79.19M